| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C51-412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C57-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C51-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709 |
| filingDate |
2016-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2018-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2018501289-A |
| titleOfInvention |
Novel crystal form of neratinib maleate and process for producing the same |
| abstract |
The present invention relates to a novel crystalline form of neratinib maleate and a method for producing the same. The novel crystalline form of the maleate salt of the compound of formula (I) of the present invention has the advantages of high solubility, excellent stability, process development, easy processing, and simple manufacturing method. Because of its low cost, it has important value in the future optimization and development of the drug. [Selection] Figure 1 |
| priorityDate |
2015-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |